Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph E Blaney

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Vaccine|September 25, 2003
Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeysStephen S Whitehead, Kathryn A Hanley, Joseph E Blaney, et al.
The American Journal of Tropical Medicine and Hygiene|January 12, 2005
Genetically modified, live attenuated dengue virus type 3 vaccine candidatesJoseph E Blaney, Christopher T Hanson, Cai-Yen Firestone, et al.
Virology Journal|March 3, 2007
Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1Joseph E Blaney, Neeraj S Sathe, Christopher T Hanson, et al.
Virus Research|December 8, 2014
Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccineAmy B Papaneri, John G Bernbaum, Joseph E Blaney, et al.
Molecular & Cellular Proteomics : MCP|December 30, 2011
Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virusJason Kindrachuk, Ryan Arsenault, Anthony Kusalik, et al.
Virology|November 12, 2013
Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaquesHaifeng Song, John Sidney, Roger W Wiseman, et al.
Virology|August 15, 2012
A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulenceAmy B Papaneri, Christoph Wirblich, Jennifer A Cann, et al.
Vaccine|July 1, 2008
Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysJoseph E Blaney, James Speicher, Christopher T Hanson, et al.
Virology|August 2, 2003
A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4Kathryn A Hanley, Luella R Manlucu, Lara E Gilmore, et al.
EJNMMI Research|June 28, 2015
The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PETSvetlana Chefer, Richard C Reba, Christopher Z Leyson, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Vaccine|September 25, 2003
Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeysStephen S Whitehead, Kathryn A Hanley, Joseph E Blaney, et al.
The American Journal of Tropical Medicine and Hygiene|January 12, 2005
Genetically modified, live attenuated dengue virus type 3 vaccine candidatesJoseph E Blaney, Christopher T Hanson, Cai-Yen Firestone, et al.
Virology Journal|March 3, 2007
Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1Joseph E Blaney, Neeraj S Sathe, Christopher T Hanson, et al.
Virus Research|December 8, 2014
Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccineAmy B Papaneri, John G Bernbaum, Joseph E Blaney, et al.
Molecular & Cellular Proteomics : MCP|December 30, 2011
Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virusJason Kindrachuk, Ryan Arsenault, Anthony Kusalik, et al.
Virology|November 12, 2013
Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaquesHaifeng Song, John Sidney, Roger W Wiseman, et al.
Virology|August 15, 2012
A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulenceAmy B Papaneri, Christoph Wirblich, Jennifer A Cann, et al.
Vaccine|July 1, 2008
Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysJoseph E Blaney, James Speicher, Christopher T Hanson, et al.
Virology|August 2, 2003
A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4Kathryn A Hanley, Luella R Manlucu, Lara E Gilmore, et al.
EJNMMI Research|June 28, 2015
The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PETSvetlana Chefer, Richard C Reba, Christopher Z Leyson, et al.
Pageof 5